Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

133
Delayed Quote. Delayed London Stock Exchange - 09/02 05:00:01 am
1458 GBp   -0.14%
2h ago LIGAND PHARMACEUTICALS : FDA to OK GlaxoSmithKline Promacta/Revolade
1d ago CIPLA : launches copy of GSK's top asthma drug in Germany, Sweden
4d ago GLAXOSMITHKLINE : Assigned Patent
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern
Recommend:
0

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
2h ago LIGAND PHARMACEUTICALS : FDA to OK GlaxoSmithKline Promacta/Revolade
1d ago CIPLA : launches copy of GSK's top asthma drug in Germany, Sweden
4d ago GLAXOSMITHKLINE : Assigned Patent
5d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consortium
5d ago GLAXOSMITHKLINE : GSK receives FDA approval for Arnuity™ Ellipta® fluticas..
5d ago GLAXOSMITHKLINE : GSK Gets FDA Approval for Arnuity Ellipta (fluticasone furoate..
6d ago GLAXOSMITHKLINE : Glaxo Says FDA Approves Promacta SNDA In Aplastic Anaemia Pati..
08/26 GLAXOSMITHKLINE : Triumeq US Approval
08/25 GLAXOSMITHKLINE : *socgen raises glaxosmithkline price target to 1920 pence - 'b..
08/22 GLAXOSMITHKLINE : ViiV Healthcare receives FDA approval for Triumeq® (abacavir, ..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF